Flexible weighted log-rank tests optimal for detecting early and/or late survival differences

Biometrics

Volumn 58, Issue 4, 2002, Pages 997-1004

  Wu, Lang ^a   Gilbert, Peter B ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

AIDS; Asymptotics; Quadratic weight; Robust test; Versatile test

Indexed keywords

DRUG THERAPY;

AIDS; AIDS CLINICAL TRIAL; ASYMPTOTICS; FOLLOW UP; QUADRATIC WEIGHT; RANK TEST; ROBUST TESTS; TIME TO EVENTS; UP PERIOD; VERSATILE TEST;

DURABILITY;

BIOMETRY; SURVIVAL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOMETRY; CALCULATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG POTENCY; FOLLOW UP; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEASUREMENT; RANK SUM TEST; REVIEW; SURVIVAL; TREATMENT OUTCOME; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036968947     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0006-341X.2002.00997.x     Document Type: Review

References (17)

1. Buyske, S., Fagerstrom, R., and Ying, Z. (2000). A class of weighted log-rank tests for survival data when the event is rare. Journal of the American Statistical Association 95, 249-258.
2. Centers for Disease Control. (1998). Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morbidity and Mortality Weekly Report 47, 43-82.
3. Davison, A. C. and Hinkley, D. V. (1997). Bootstrap Methods and Their Application. Cambridge, U.K.: Cambridge University Press.
4. Fleming, T. R. and Harrington, D. P. (1991). Counting Processes and Survival Analysis. New York: Wiley.
5. Fleming, T. R., Harrington, D. P., and O'Sullivan, M. (1987). Supremum versions of the log-rank and generalized Wilcoxon statistics. Journal of the American Statistical Association 82, 312-320.
6. Gastwirth, J. L. (1966). On robust procedures. Journal of the American Statistical Association 61, 929-948.
7. Genz, A. (1992). Numerical computation of multivariate normal probabilities. Journal of Computational and Graphical Statistics 1, 141-149.
8. Gilbert, P. B., Ribaudo, H. J., Greenberg, L., Yu, G., Bosch, R., and Tierney, C. (2000). Considerations in choosing a primary endpoint that measures durability of virologic suppression in an antiretroviral trial. AIDS 14, 1-12.
9. Gilbert, P. B., Wei, L. J., Kosorok, M. R., and Clemens, J. D. (2002). Simultaneous inference on the contrast of two hazard functions. Biometrics, in press.
10. Golub, G. H. (1963). Comparison of the variance of minimum variance and weighted least squares regression coefficients. Annals of Mathematical Statistics 43, 984-991.
11. Gray, R. J. and Tsiatis, A. A. (1989). A linear rank test for use when the main interest is in differences in cure rates. Biometrics 45, 899-904.
12. Luenberger, D. G. (1984). Linear and Nonlinear Programming, 2nd edition. Reading, Massachusetts: Addison-Wesley.
13. Self, S. G. (1991). An adaptive weighted logrank test with application to cancer prevention and screening trials. Biometrics 47, 975-986.
14. Shen, Y. and Cai, J. (2001). Maximum of the weighted Kaplan-Meier tests with application to cancer prevention and screening trials. Biometrics 57, 837-843.
15. Stablein, D. M., Carter, W. H., and Novak, J. W. (1981). Analysis of survival data with nonproportional hazard functions. Controlled Clinical Trials 2, 149-159.
16. Wong, J. K., Hezareh, M., Gunthard, H. F., Havlir, D. V., Ignacio, C. C., Splina, C. A., and Richman, D. D. (1997). Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291-1295.
17. Zucker, D. M. and Lakatos, E. (1990). Weighted log rank type statistics for comparing survival curves when there is a time lag in the effectiveness of treatment. Biometrika 77, 853-864.